$SNSS Headlines Stocks to Watch Friday: Analogic
Post# of 94274
Posted On: 12/13/2013 9:40:20 AM
$SNSS Headlines
Stocks to Watch Friday: Analogic, Werner 3:36 p.m. Sept. 13, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 2:39 p.m. Sept. 13, 2012 - MarketWatch
Stocks to Watch Wednesday: Texas Instruments 4:25 p.m. Sept. 11, 2012 - David B. Wilkerson
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Sunesis Pharma up 57% in premarket 7:46 a.m. Sept. 11, 2012 - Steve Gelsi
ASCO studies shake up drug stocks 3:17 p.m. June 7, 2011 - Val Brickates Kennedy
Exelixis, Sunesis lead drug stocks lower 2:42 p.m. June 6, 2011 - Val Brickates Kennedy
Sunesis tumbles 16% in early trading 9:27 a.m. June 6, 2011 - Val Brickates Kennedy
Sunesis Pharmaceuticals Initiates Investigator-Sponsored Trial Evaluating Vosaroxin in Combination With Azacitidine in MDS 6:05 a.m. Dec. 10, 2013 - benzinga.com
Sunesis Pharmaceuticals' CEO Presents at the Piper Jaffray Healthcare Conference 2013 10:38 p.m. Dec. 3, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 4:20 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 3:20 p.m. Nov. 12, 2013 - Seeking Alpha
Sunesis Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 10:55 a.m. Nov. 12, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Announces Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome 5:07 a.m. Oct. 28, 2013 - benzinga.com
Interview With Cowen's Dr. Eric Schmidt: These 2 Biotech Stocks Could Outperform 10:45 a.m. Oct. 16, 2013 - Seeking Alpha
2014 Isn't Looking To Good For Eli Lilly And Company 2:34 p.m. Sept. 30, 2013 - Seeking Alpha
2014 Isn't Looking To Good For Eli Lily And Company 2:34 p.m. Sept. 30, 2013 - Seeking Alpha
Sunesis' CEO Presents at BioCentury's 2013 Newsmakers in the Biotech Industry Conference (Transcript) 11:11 a.m. Sept. 27, 2013 - Seeking Alpha
Does Conatus Pharmaceuticals Have A Winner With Emricasan? 5:21 p.m. Sept. 25, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 3:56 p.m. Aug. 2, 2013 - Edgar Online - (EDG = 10Q, 10K)
Benzinga's Top Initiations 7:01 a.m. July 31, 2013 - benzinga.com
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial With no Change to Study Conduct 5:10 a.m. June 13, 2013 - benzinga.com
Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 12:30 PM 6:20 p.m. May 21, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript 6:10 p.m. May 9, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 3:19 p.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals Earnings: Here’s Why the Stock is Up Now 9:16 a.m. May 9, 2013 - Wall St. Cheat Sheet
Hedge Funds Are Buying 3 Undervalued Stocks With Short Covering 3:23 p.m. March 26, 2013 - Seeking Alpha
Vosaroxin: A Promising Drug For A Difficult Disease 3:29 p.m. March 21, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Evaluating Vosaroxin in Combination With Azacitidine in MDS 7:00 a.m. Dec. 10, 2013 - GlobeNewswire
Sunesis Pharmaceuticals to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:00 a.m. Nov. 27, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Reports Third Quarter Financial Results and Recent Highlights 7:00 a.m. Nov. 12, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Credit Suisse Annual Health Care Conference 7:00 a.m. Nov. 6, 2013 - GlobeNewswire
Sunesis to Host Conference Call on November 12th to Discuss Third Quarter Financial Results and Recent Highlights 7:00 a.m. Nov. 5, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Announces Initiation of Phase 2 Cohort of MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS 6:00 a.m. Oct. 30, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome 6:00 a.m. Oct. 28, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Completes Enrollment in Phase 3 VALOR Trial of Vosaroxin in AML 8:23 a.m. Sept. 25, 2013 - GlobeNewswire
Sunesis to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference 6:00 a.m. Sept. 19, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Stifel Nicolaus Healthcare Conference 6:00 a.m. Sept. 4, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Wedbush Life Sciences Management Access Conference 6:00 a.m. Aug. 7, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on ALU, BYD, SNSS and STXS 7:50 a.m. July 31, 2013 - ACCESSWIRE
Sunesis Pharmaceuticals Reports Second Quarter Financial Results and Recent Highlights 3:01 p.m. July 29, 2013 - GlobeNewswire
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial With no Change to Study Conduct 6:00 a.m. June 13, 2013 - GlobeNewswire
Sunesis to Present at the Wells Fargo 2013 Healthcare Conference 1:25 p.m. June 12, 2013 - GlobeNewswire
Vosaroxin Review Published in Expert Opinion on Pharmacotherapy 6:01 a.m. May 30, 2013 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 2:30 p.m. May 10, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights 6:00 a.m. May 9, 2013 - GlobeNewswire
Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights 6:01 a.m. May 2, 2013 - GlobeNewswire
Sunesis to Present at the Needham & Company 12th Annual Healthcare Conference 6:00 a.m. April 24, 2013 - GlobeNewswire
Stocks to Watch Friday: Analogic, Werner 3:36 p.m. Sept. 13, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 2:39 p.m. Sept. 13, 2012 - MarketWatch
Stocks to Watch Wednesday: Texas Instruments 4:25 p.m. Sept. 11, 2012 - David B. Wilkerson
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Sunesis Pharma up 57% in premarket 7:46 a.m. Sept. 11, 2012 - Steve Gelsi
ASCO studies shake up drug stocks 3:17 p.m. June 7, 2011 - Val Brickates Kennedy
Exelixis, Sunesis lead drug stocks lower 2:42 p.m. June 6, 2011 - Val Brickates Kennedy
Sunesis tumbles 16% in early trading 9:27 a.m. June 6, 2011 - Val Brickates Kennedy
Sunesis Pharmaceuticals Initiates Investigator-Sponsored Trial Evaluating Vosaroxin in Combination With Azacitidine in MDS 6:05 a.m. Dec. 10, 2013 - benzinga.com
Sunesis Pharmaceuticals' CEO Presents at the Piper Jaffray Healthcare Conference 2013 10:38 p.m. Dec. 3, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 4:20 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 3:20 p.m. Nov. 12, 2013 - Seeking Alpha
Sunesis Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 10:55 a.m. Nov. 12, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Announces Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome 5:07 a.m. Oct. 28, 2013 - benzinga.com
Interview With Cowen's Dr. Eric Schmidt: These 2 Biotech Stocks Could Outperform 10:45 a.m. Oct. 16, 2013 - Seeking Alpha
2014 Isn't Looking To Good For Eli Lilly And Company 2:34 p.m. Sept. 30, 2013 - Seeking Alpha
2014 Isn't Looking To Good For Eli Lily And Company 2:34 p.m. Sept. 30, 2013 - Seeking Alpha
Sunesis' CEO Presents at BioCentury's 2013 Newsmakers in the Biotech Industry Conference (Transcript) 11:11 a.m. Sept. 27, 2013 - Seeking Alpha
Does Conatus Pharmaceuticals Have A Winner With Emricasan? 5:21 p.m. Sept. 25, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 3:56 p.m. Aug. 2, 2013 - Edgar Online - (EDG = 10Q, 10K)
Benzinga's Top Initiations 7:01 a.m. July 31, 2013 - benzinga.com
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial With no Change to Study Conduct 5:10 a.m. June 13, 2013 - benzinga.com
Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 12:30 PM 6:20 p.m. May 21, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript 6:10 p.m. May 9, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 3:19 p.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals Earnings: Here’s Why the Stock is Up Now 9:16 a.m. May 9, 2013 - Wall St. Cheat Sheet
Hedge Funds Are Buying 3 Undervalued Stocks With Short Covering 3:23 p.m. March 26, 2013 - Seeking Alpha
Vosaroxin: A Promising Drug For A Difficult Disease 3:29 p.m. March 21, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Evaluating Vosaroxin in Combination With Azacitidine in MDS 7:00 a.m. Dec. 10, 2013 - GlobeNewswire
Sunesis Pharmaceuticals to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:00 a.m. Nov. 27, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Reports Third Quarter Financial Results and Recent Highlights 7:00 a.m. Nov. 12, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Credit Suisse Annual Health Care Conference 7:00 a.m. Nov. 6, 2013 - GlobeNewswire
Sunesis to Host Conference Call on November 12th to Discuss Third Quarter Financial Results and Recent Highlights 7:00 a.m. Nov. 5, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Announces Initiation of Phase 2 Cohort of MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS 6:00 a.m. Oct. 30, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome 6:00 a.m. Oct. 28, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Completes Enrollment in Phase 3 VALOR Trial of Vosaroxin in AML 8:23 a.m. Sept. 25, 2013 - GlobeNewswire
Sunesis to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference 6:00 a.m. Sept. 19, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Stifel Nicolaus Healthcare Conference 6:00 a.m. Sept. 4, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Wedbush Life Sciences Management Access Conference 6:00 a.m. Aug. 7, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on ALU, BYD, SNSS and STXS 7:50 a.m. July 31, 2013 - ACCESSWIRE
Sunesis Pharmaceuticals Reports Second Quarter Financial Results and Recent Highlights 3:01 p.m. July 29, 2013 - GlobeNewswire
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial With no Change to Study Conduct 6:00 a.m. June 13, 2013 - GlobeNewswire
Sunesis to Present at the Wells Fargo 2013 Healthcare Conference 1:25 p.m. June 12, 2013 - GlobeNewswire
Vosaroxin Review Published in Expert Opinion on Pharmacotherapy 6:01 a.m. May 30, 2013 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 2:30 p.m. May 10, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights 6:00 a.m. May 9, 2013 - GlobeNewswire
Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights 6:01 a.m. May 2, 2013 - GlobeNewswire
Sunesis to Present at the Needham & Company 12th Annual Healthcare Conference 6:00 a.m. April 24, 2013 - GlobeNewswire
(0)
(0)